Yesterday the announcement came, looks like NRSN is going to find a cure for deadly ALS (Stephen Hawking’s disease). Normally patients only live 3-5 years after diagnosis.
Currently there's no cure for ALS, but several treatments can control symptoms, prevent complications, and ease living with the disease. This market’s value USD 673M in 2023 and is further anticipated to reach USD 1,2B by 2033. (https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-market-track-152100760.html)
NRSN’s announced results showing promising survival rates, looks like they have developed a drug for curing ALS. Here is the link: https://www.stocktitan.net/news/NRSN/neuro-sense-s-paradigm-als-clinical-trial-demonstrates-up-to-73-31gn7cz2pykc.html
What do you guys think? Is it a good buy opportunity?
Submitted July 10, 2024 at 03:58AM by Checkinginstealth https://ift.tt/Y4BtOTu
